Warning: The NCBI web site requires JavaScript to function. more...
Diabetic retinopathy: current management and experimental therapeutic targets.
Ali TK, El-Remessy AB.
Pharmacotherapy. 2009 Feb;29(2):182-92. Review.PMID: 19170588 [PubMed - indexed for MEDLINE]Related articles
Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB, Obrosova IG.
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1778-90. Epub 2008 Dec 20.PMID: 19098320 [PubMed - indexed for MEDLINE]Related articles
Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.
Int J Mol Med. 2008 Jun;21(6):667-76.PMID: 18506358 [PubMed - indexed for MEDLINE]Related articlesFree article
Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.
Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB.
Diabetes. 2008 Apr;57(4):889-98. Epub 2008 Feb 19.PMID: 18285558 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Int J Mol Med. 2008 Jun; 21(6):667-76.
[Int J Mol Med. 2008]
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...